Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free AVTX Stock Alerts

Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts

Avalo Therapeutics logo
$19.30 -0.15 (-0.75%)
As of 01:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Avalo Therapeutics Earnings Summary

Avalo Therapeutics announced Q2 2026 earnings on August 6, 2026, reporting an EPS of -$0.83, which missed the consensus estimate of -$0.58 by $0.25. With a trailing EPS of -$4.37, Avalo Therapeutics' earnings are expected to grow next year, from ($2.59) to ($2.53) per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
-$0.58
Actual EPS
(Aug. 6)
-$0.83 Missed By -$0.25

Q2 2026 Earnings Resources

Powered by Quartr
Get Avalo Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avalo Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

AVTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avalo Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.44-$1.10-$1.27
Q2 20262-$0.93-$0.59-$0.76
Q3 20262-$0.89-$0.58-$0.74
Q4 20262-$0.93-$0.58-$0.76
FY 2026 8 -$4.19 -$2.85 -$3.52
Q1 20271-$0.59-$0.59-$0.59
Q2 20271-$0.59-$0.59-$0.59
Q3 20271-$0.61-$0.61-$0.61
Q4 20271-$0.62-$0.62-$0.62

Avalo Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026-$0.5827-$0.83 -$0.2473-$0.83--
5/13/2026Q1 2026-$1.00-$0.98+$0.02-$0.98$0.05M-
3/23/2026Q4 2025-$1.54-$0.37+$1.17-$0.37-$0.21M$0.06M
11/6/2025Q3 2025-$1.67-$2.19 -$0.52-$2.19--
8/7/2025Q2 2025-$1.43-$1.92 -$0.49-$1.92--
5/12/2025Q1 2025-$1.07-$1.25 -$0.18-$1.25--

Avalo Therapeutics Earnings - Frequently Asked Questions

Avalo Therapeutics (NASDAQ:AVTX) last announced its quarterly earning data on Thursday, August 6, 2026. Learn more on AVTX's earnings history.

In the previous quarter, Avalo Therapeutics (NASDAQ:AVTX) missed the analysts' consensus estimate of ($0.58) by $0.25 with a reported earnings per share (EPS) of ($0.83). Learn more on analysts' earnings estimate vs. AVTX's actual earnings.

Avalo Therapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $60,000.00.

Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$78.26 million. AVTX has generated -$4.37 earnings per share over the last four quarters.

Avalo Therapeutics' earnings are expected to grow from ($2.59) per share to ($2.53) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:AVTX is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...
Decentralized Masters | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel